(Q61915435)
Statements
A Phase II Study of Anakinra (IL-1 Receptor Antagonist) in Patients With Smoldering/Indolent Multiple Myeloma (English)
0 references
December 2002
0 references
December 2009
0 references
55
0 references
18 year
0 references
120 year
0 references